<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Characteristics according to the ATA risk stratification system and AJCC/TNM staging system that may impact postoperative radioiodine decision-making</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Characteristics according to the ATA risk stratification system and AJCC/TNM staging system that may impact postoperative radioiodine decision-making</h1>
<div class="graphic"><div class="figure"><div class="ttl">Characteristics according to the ATA risk stratification system and AJCC/TNM staging system that may impact postoperative radioiodine decision-making</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="15%"></colgroup><colgroup width="40%"></colgroup> <tbody> <tr> <td class="subtitle1">ATA risk staging (TNM)</td> <td class="subtitle1">Description</td> <td class="subtitle1">Body of evidence suggests RAI improves disease specific survival?</td> <td class="subtitle1">Body of evidence suggests RAI improves disease free survival?</td> <td class="subtitle1">Postsurgical RAI indicated?</td> </tr> <tr class="divider_bottom"> <td> <ul> <li>ATA low risk </li> <li>T1a </li> <li>N0, Nx </li> <li>M0, Mx </li> </ul> </td> <td>Tumor size ≤1 cm (uni- or multifocal)</td> <td>No</td> <td>No</td> <td>No</td> </tr> <tr class="divider_bottom"> <td> <ul> <li>ATA low risk </li> <li>T1b, T2 </li> <li>N0, Nx </li> <li>M0, Mx </li> </ul> </td> <td>Tumor size &gt;1 to 4 cm</td> <td>No</td> <td>Conflicting observational data</td> <td>Not routine* — May be considered for patients with aggressive histology or vascular invasion (ATA intermediate risk).</td> </tr> <tr class="divider_bottom"> <td> <ul> <li>ATA low to intermediate risk </li> <li>T3 </li> <li>N0, Nx </li> <li>M0, Mx </li> </ul> </td> <td>Tumor size &gt;4 cm</td> <td>Conflicting data</td> <td>Conflicting observational data</td> <td>Consider* — Need to consider presence of other adverse features. Advancing age may favor RAI use in some cases, but specific age and tumor size cutoffs subject to some uncertainty.<sup>¶</sup></td> </tr> <tr class="divider_bottom"> <td> <ul> <li>ATA low to intermediate risk </li> <li>T3 </li> <li>N0, Nx </li> <li>M0, Mx </li> </ul> </td> <td>Microscopic ETE, any tumor size</td> <td>No</td> <td>Conflicting observational data</td> <td>Consider* — Generally favored based on risk of recurrent disease. Smaller tumors with microscopic ETE may not require RAI.</td> </tr> <tr class="divider_bottom"> <td> <ul> <li>ATA low to intermediate risk </li> <li>T1-3 </li> <li>N1a </li> <li>M0, Mx </li> </ul> </td> <td>Central compartment neck lymph node metastases</td> <td>No, except possibly in subgroup of patients ≥45 years of age (NTCTCSG Stage III)</td> <td>Conflicting observational data</td> <td>Consider* — Generally favored, due to somewhat higher risk of persistent or recurrent disease, especially with increasing number of large (&gt;2 to 3 cm) or clinically evident lymph nodes or presence of extranodal extension. Advancing age may also favor RAI use.<sup>¶</sup> However, there is insufficient data to mandate RAI use in patients with few (&lt;5) microscopic nodal metastases in central compartment in absence of other adverse features.</td> </tr> <tr class="divider_bottom"> <td> <ul> <li>ATA low to intermediate risk </li> <li>T1-3 </li> <li>N1b </li> <li>M0, Mx </li> </ul> </td> <td>Lateral neck or mediastinal lymph node metastases</td> <td>No, except possibly in subgroup of patients ≥45 years of age</td> <td>Conflicting observational data</td> <td>Consider* — Generally favored, due to higher risk of persistent or recurrent disease, especially with increasing number of macroscopic or clinically evident lymph nodes or presence of extranodal extension. Advancing age may also favor RAI use.<sup>¶</sup></td> </tr> <tr class="divider_bottom"> <td> <ul> <li>ATA high risk </li> <li>T4 </li> <li>Any N </li> <li>Any M </li> </ul> </td> <td>Any size, gross ETE</td> <td>Yes, observational data</td> <td>Yes, observational data</td> <td>Yes</td> </tr> <tr> <td> <ul> <li>ATA high risk </li> <li>M1 </li> <li>Any T </li> <li>Any N </li> </ul> </td> <td>Distant metastases</td> <td>Yes, observational data</td> <td>Yes, observational data</td> <td>Yes</td> </tr> </tbody></table></div><div class="graphic_footnotes">AJCC: American Joint Committee on Cancer; ATA: American Thyroid Association; ETE: extrathyroidal extension; NTCTCSG: National Thyroid Cancer Treatment Cooperative Study Group; RAI: radioiodine; Tg: thyroglobulin; US: ultrasound.<br/>* In addition to standard clinicopathologic features, local factors such as the quality of preoperative and postoperative US evaluations, availability and quality of Tg measurements, experience of the operating surgeon, and clinical concerns of the local disease management team may also be considerations in postoperative RAI decision-making.<br/>¶ Recent data from the NTCTCSG have suggested that a more appropriate prognostic age cutoff for their and other classification systems could be 55 years, rather than 45 years, particularly for women.</div><div class="graphic_reference">Reproduced with permission from: Bryan RH, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016; 26:1. Copyright © 2016 Mary Ann Liebert, Inc. Publishers. All rights reserved.</div><div id="graphicVersion">Graphic 107641 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
